States of Intoxication: Risks and Adverse Effects Focus on Non-Medical Cannabis and Synthetic Cannabinoids

被引:0
|
作者
Bonnet, U. [1 ]
机构
[1] Evangel Krankenhaus Castrop Rauxel, Klin Psychiat Psychotherapie & Psychosomat, Grutholzallee 21, D-44577 Castrop Rauxel, Germany
关键词
intoxication; cannabis; synthetic cannobinoids; health risk; DELTA-9-TETRAHYDROCANNABINOLIC ACID; DRUG-USE; MARIJUANA; TOBACCO; TRENDS; DEPENDENCE; COLORADO; SEQUELAE; OUTCOMES; AMERICA;
D O I
10.1055/s-0042-101584
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In the context of the ongoing debate about the legalization of cannabis this article is focused in its general part on some common characteristics of intoxication itself and in its special part on the risks and adverse effects of the non-medical use of cannabis and synthetic cannabinoids. It is summarized that i) cannabis use is particularly prevalent among young adults, ii) the regular use of cannabis is decreasing among German teenagers (2011: 0.8 %), iii) 0.5 % of German adults are currently dependent on cannabis (DSM-IV), iv) the greatest health risks and psychosocial disabilities are expected to occur in regularly consuming young people and adult cannabis-dependents, v) both, the rate of the general disability and the health risks related to the use of cannabis are lower than those related to the use of alcohol, vi) most psychic and physical sequelae of regular cannabis use are reversible in adults in the course of their abstinence; if the regular use had started in the adolescence or later; an earlier regular use is associated with sustaining impairments of executive functioning in adulthood vii) the risk of schizophrenia in regular cannabis users is doubled at least, viii) in modern cannabis strains the content of THC as well as cannabidiol had markedly increased and decreased, respectively, ix) the health risk subsequent to the consumption of synthetic cannabinoids is much higher than the health risk subsequent to the use of cannabis and is increasingly unpredictable, x) the number of emergency department visits involving the use of cannabis and synthetic cannabinoids are increasing and xi) children and young people are to be protected to prevent that substance use impedes their brain maturation and socialization/individual development by continuous consumption. In US-states, where cannabis had been legalized there exists a trend to increasing cannabis-related fatal traffic accidents, cyclic hyperemesis, emergency department visits and requests to Poison and Drug Centres. On the other hand, a decrease of deaths by overdose with opioide painkillers was observed.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [1] Adverse health effects of non-medical cannabis use
    Parakh, Preeti
    LANCET, 2010, 375 (9710): : 196 - 197
  • [2] Adverse health effects of non-medical cannabis use
    Hall, Wayne
    Degenhardt, Louisa
    LANCET, 2009, 374 (9698): : 1383 - 1391
  • [3] Adverse health effects of non-medical cannabis use reply
    Hall, Wayne
    Degenhardt, Louisa
    LANCET, 2010, 375 (9710): : 197 - 197
  • [4] The adverse public health effects of non-medical cannabis legalisation in Canada and the USA
    Yimer, Tesfa Mekonen
    Hoch, Eva
    Fischer, Benedikt
    Dawson, Danielle
    Hall, Wayne
    LANCET PUBLIC HEALTH, 2025, 10 (02): : e148 - e159
  • [5] Adverse effects of cannabis and cannabinoids
    Ashton, CH
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (04) : 637 - 649
  • [6] Adverse effects of cannabis and cannabinoids
    Ashton, CH
    BRITISH JOURNAL OF ANAESTHESIA, 2000, 84 (03) : 420 - 420
  • [7] Adverse Effects and Detection of Synthetic Cannabinoids
    Oyemade, Adegboyega
    AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (06): : 568 - 569
  • [8] Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits
    Hoch, E.
    Volkow, N. D.
    Friemel, C. M.
    Lorenzetti, V.
    Freeman, T. P.
    Hall, W.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2025, 275 (02) : 281 - 292
  • [9] Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review
    Wolfe, Dianna
    Corace, Kimberly
    Rice, Danielle
    Smith, Andra
    Kanji, Salmaan
    Conn, David
    Willows, Melanie
    Garber, Gary E.
    Puxty, John
    Moghadam, Esther
    Skidmore, Becky
    Garritty, Chantelle
    Thavorn, Kednapa
    Moher, David
    Hutton, Brian
    BMJ OPEN, 2020, 10 (02):
  • [10] An antenatal prediction model for adverse birth outcomes in an urban population: The contribution of medical and non-medical risks
    Posthumus, A. G.
    Birnie, E.
    van Veen, M. J.
    Steegers, E. A. P.
    Bonsel, G. J.
    MIDWIFERY, 2016, 38 : 78 - 86